[Research Report] The bovine diagnostics market was valued at US$ 1,155.59 million in 2022 and is expected to reach US$ 2,011.15 million by 2030. It is estimated to register a CAGR of 7.2% during 2022–2030.

Market Insights and Analyst View:

Developments in the global healthcare sector such as growing digitalization and automation define the growth of the bovine diagnostics market. Technological advancements and automation have led to smart laboratories and imaging services. In addition, the awareness of animal health and availability of veterinary diagnostics have led to the overall growth of the veterinary diagnostics market. Moreover, there is a growing demand for bovine diagnostics from cattle farmers to enhance the health of their herds to obtain the best-quality meat, dairy products, and other food and commercial products.

The growing adoption of artificial intelligence technologies in veterinary diagnostics is likely to substantially benefit the progress of the bovine diagnostics market. Also, the increasing use of liquid biopsies and point-of-care products is expected to serve good growth opportunities in the bovine diagnostics market in the coming years. Ongoing and anticipated mergers, collaborations, and strategic decisions by key players would further drive the progress of the bovine diagnostics market in the future.

Growth Drivers and Challenges:

Bovine mastitis is a global concern that incurs huge economic losses to the global agriculture sector. Mastitis results in lowered milk production in affected animals and causes continuous veterinary expenses, resulting in reduced profitability for dairy farmers. According to the estimates published by Thermo Fisher Scientific in July 2022, the total annual cost to the global dairy industry caused by mastitis is between US$ 19.7 billion to US$ 32 billion. In the US alone, the cost of subclinical mastitis is expected to exceed to US$ 1 billion annually. Therefore, continuous monitoring and risk analysis are required to prevent huge economic losses. As per the National Bureau of Statistics of China 2022, China has cattle counts of 102.16 million while milk production is 39.32 million tons. The published data also stated that the prevalence of bovine mastitis is ~60–70%, and clinical mastitis accounts for ~21–23% mortality in cattle. Further, the data revealed that dairy mastitis costs ~US$ 15–45 billion to China every year.

According to the study “Global and countrywide prevalence of subclinical and clinical mastitis in dairy cattle and buffaloes by systematic review and meta-analysis,” published in April 2021, the global pooled prevalence of subclinical mastitis (SCM) and clinical mastitis (CM) were 42% and 15%, respectively, during 2011–2019. In India, the prevalence of SCM and CM were 45% and 18%, respectively, during 2011–2019. The study also stated that North America and Europe had a higher prevalence of SCM, while countries such as the UK and Uganda had a higher prevalence of CM. The prevalence of mastitis is expected to increase due to the prolonged history of the disease in the dairy industry. The facts and data from across the world indicate the high prevalence of clinical mastitis, which triggers the demand for bovine diagnostics. Moreover, surveillance programs and good management systems introduced by governments in different countries support the bovine diagnostics market.

The lack of skilled professionals in veterinary research hinders the bovine diagnostics market growth. Factors such as the lack of suitable remuneration guarantees, the risk of animal-borne disorders, and concerns regarding ethics and animal welfare make veterinary research a less attractive field for workforces. Owing to technological advancements and the changing work nature, the requirement for skilled veterinary professionals capable of operating sophisticated tools and devices has increased. Meanwhile, businesses in veterinary medicine seek candidates with advanced management skills to propel larger, more complex businesses. According to the US National Research Council Committee, veterinary research institutes and companies face challenges in maintaining the economic sustainability of veterinary practices and education, and transforming their veterinary services to meet changing societal needs.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Bovine Diagnostics Market: Strategic Insights

Market Size Value in	US$ 1,155.59 million in 2022
Market Size Value by	US$ 2,011.15 million by 2030
Growth rate	CAGR of 7.2% from 2022 to 2030
Forecast Period	2022-2030
Base Year	2022

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

 Speak to Analyst

Report Segmentation and Scope:

The bovine diagnostics market is segmented on the basis of product, disease type, and end user. Based on product, the market is classified into immunoassay kits, PCR reagents & kits, hemagglutination inhibition (HI) assay, and other products. The market growth of the immunoassay kits segment is attributed to the use of kits for various clinical diagnoses, innovative offerings by key players, and technological advancements in test kits.

Based on the disease type, the bovine diagnosticsmarket is segmented into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and others. The growth of the market for disease type is attributed to the occurrence of various bovine diseases and the availability of key players offering diagnostics kits for these diseases.

Based on end user, the bovine diagnostics market is classified into veterinary hospitals, veterinary clinics, and others. The growth of the market by end user is attributed to support from governments and growing research on bovine diseases. Based on geography, the bovine diagnostics market is divided into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Segmental Analysis:

Based on product, the bovine diagnostics market is segmented into immunoassay kits, PCR kits, hemagglutination inhibition (HI) assay, and others. The immunoassay kits segment is estimated to be the largest and fastest-growing segment in the market during 2022–2030. An immunoassay kit uses immunological proteins and antibodies to detect molecules of interest. These molecules can be any antigen such as bacteria, viruses, hormones, or antibodies. Antigens are molecules against which the body produces an immune response. Laboratory bench-top kits, known as enzyme-linked immunosorbent assays (ELISA) kits, are used in laboratories, clinical settings, and veterinary industry. Clinical settings and core facilities typically use larger instrumentation for assays, such as latex turbidity immunoassays (LTIA) and chemiluminescent immunoassays (CLIA). The immunoassay kits are used for various clinical diagnosis such as haptoglobin in biological samples of cattle, bovine lumpy skin disease (LSDV), quantitative detection of bovine IgM, and foot and mouth disease virus in cattle.

Many companies offer a wide range of immunoassay kits for diagnosis of bovine diseases. Innovative Research offers the Bovine IgM ELISA Kit, which is a highly sensitive two-site ELISA for measuring IgM in bovine biological samples for up to 96 tests. Thus, application of immunoassay kits for various clinical diagnosis and offering by key players promote the bovine diagnostics market growth for the immunoassay kits segment.

Bovine Diagnostics Market, by Product – 2022 and 2030

Access Data

Based on disease type, the bovine diagnostics market is categorized into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and others. The bovine mastitis segment held the largest market share in 2022 and is also anticipated to register the highest CAGR during 2022–2030.

On the basis of end user, the bovine diagnostics market is segmented into veterinary hospitals, veterinary clinics, and others. The veterinary hospitals segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR during 2022–2030.

Regional Analysis:

Based on geography, the bovine diagnostics market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the largest contributor to the growth of the market, and Asia Pacific is expected to record the fastest CAGR during 2022–2030. The factors that are leading the growth of market in North America are the increasing number of product launches and government initiatives, and ongoing developments in diagnostics technologies. The US holds the largest share of the bovine diagnostics market in North America. The bovine diagnostics market growth in the US is attributed to the rising government efforts to control zoonotic diseases, mastitis, and tuberculosis. Continuous developments in veterinary diagnostics result in frequent bovine diagnostics product launches. In October 2022, the Kansas State Veterinary Diagnostic Laboratory of the Kansas State University College of Veterinary Medicine developed a test to detect two major blood-borne diseases in cattle. Researchers at Kansas State Veterinary Diagnostic Laboratory developed a polymerase chain reaction (PCR) technique to detect endemic anaplasmosis and emerging theileriosis. The test will allow veterinarians and cattle farmers to diagnose the herds with disease-causing microorganisms, and help them effectively prevent and manage the diseases. In June 2023, Neogen Corporation launched Igenity BeefXDairy. It is a novel genomic test for beef-on-dairy calves. Igenity BeefXDairy provides insights about some key traits, including carcass quality, average daily gain, and the Igenity Terminal Index. These insights help calf producers to market their cattle to potential buyers.

The increasing incidences of bovine tuberculosis (bTB) and bovine viral diarrhea in cattle, rising demand for milk and meat products, and surging government initiatives for bovine diagnostics benefit the bovine diagnostics market growth in Asia Pacific.

Industry Developments and Future Opportunities:

Various initiatives by key players operating in the bovine diagnostics market are listed below:

1. In July 2023, PBD Biotech, a developer of a ground-breaking phage-based diagnostic tool for laboratory tuberculosis testing, secured a US patent for its Actiphage TB diagnostic kit. Grant of this US patent is related to the detection of Mycobacteria using bacteriophages, specifically to the diagnostic kit, providing intellectual property rights to the company for its Actiphage technology.
2. In June 2023, Ringbio, a Chinese biotechnology company, participated in the Dairy, Livestock, and Poultry Technology Exhibition Africa 2023 (DLP Expo Africa 2023), held at Kenyatta International Convention Centre, Kenya, from June 15th to 17th. Ringbio displayed its products and solutions for food safety, animal disease, and clinical testing at the expo. A few of the featured products included Bovine Pregnancy Rapid Test Kit & Solutions, Cattle Tests, and Goat/sheep Tests.
3. In March 2021, PBD Biotech secured US$ 3.16 million of investment to take Actiphage through to the World Organisation for Animal Health (OIE) validation. Actiphage is a rapid, accurate test for bovine tuberculosis diagnosis, which would enable farmers to effectively remove the devastating disease from their herds. Its full validation would further enable international adoption of this novel, patented diagnostic tool for mycobacterial diseases, including human tuberculosis and Johne’s disease.

COVID-19 Impact:

The bovine diagnostics market players experienced a steady increase in demand before the onset of the COVID-19 pandemic. These diagnostics mainly include ELISA, PCR, and hemagglutination inhibition (HI) assays. Bovine diseases can be controlled by performing diagnostic tests to screen infected cattle for culling or segregation while keeping most ELISA-positive cattle posing a low risk of infections to other animals in the herd.

The bovine diagnostics market declined notably after the onset of the COVID-19 pandemic amid the lockdown measures implemented in several nations, which led to the shutdown of veterinary clinics. This scenario made it difficult for cattle farmers to obtain proper veterinary diagnosis and treatment because of the cancellation and reduction of veterinarian appointments. Despite the health crisis across the world, various initiatives were taken by governments of different countries and companies in the veterinary therapeutics industry to continue their eradication programs. For instance, according to the Michigan Department of Agriculture and Rural Development (MDARD), activities under the Bovine Tuberculosis Eradication Program in the US, including testing cattle for TB, continued while precautions were taken to prevent COVID-19 spread.

Competitive Landscape and Key Companies:

A few prominent players operating in the bovine diagnostics market are Idexx Laboratories Inc, PBD Biotech Ltd, Thermo Fisher Scientific Inc, Innovative Diagnostics SAS, Neogen Corp, Enfer Labs, bioMerieux SA, Ring Biotechnology Co Ltd, Bionote Inc, and Shenzhen Bioeasy Biotechnology Co Ltd. These companies focus on new product launches and geographic expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. Their global presence allows them to serve a large set of customers, subsequently allowing them to expand their market share.